News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
120,960 Results
Type
Article (13210)
Company Profile (65)
Press Release (107685)
Multimedia
Podcasts (16)
Webinars (4)
Section
Business (30684)
Career Advice (692)
Deals (5058)
Drug Delivery (38)
Drug Development (16822)
Employer Resources (45)
FDA (2610)
Job Trends (3438)
News (54741)
Policy (4899)
Tag
2027 Genetown Elite (1)
2027 Genetown Standard (1)
2027 Pharm Country Standard (1)
Academia (809)
Accelerated approval (13)
Adcomms (7)
Allergies (42)
Alliances (9628)
ALS (44)
Alzheimer's disease (391)
Antibody-drug conjugate (ADC) (51)
Approvals (2688)
Artificial intelligence (115)
Autoimmune disease (25)
Automation (6)
Bankruptcy (26)
Best Places to Work (3065)
BIOSECURE Act (4)
Biosimilars (24)
Biotechnology (51)
Bladder cancer (38)
Brain cancer (22)
Breast cancer (107)
Cancer (1112)
Cardiovascular disease (114)
Career advice (604)
Career pathing (17)
CAR-T (82)
CDC (6)
Celiac Disease (1)
Cell therapy (236)
Cervical cancer (1)
Clinical research (13895)
Collaboration (442)
Compensation (195)
Complete response letters (16)
COVID-19 (561)
CRISPR (57)
C-suite (177)
Cystic fibrosis (93)
Data (1698)
Decentralized trials (1)
Denatured (4)
Depression (34)
Diabetes (99)
Diagnostics (1813)
Digital health (4)
Diversity (4)
Diversity, equity & inclusion (17)
Drug discovery (69)
Drug pricing (33)
Drug shortages (5)
Duchenne muscular dystrophy (126)
Earnings (10646)
Editorial (27)
Employer branding (8)
Employer resources (48)
Events (17066)
Executive appointments (150)
FDA (3383)
Fibrodysplasia Ossificans Progressiva (4)
Friedreich's ataxia (9)
Frontotemporal dementia (11)
Funding (308)
Gene editing (138)
Generative AI (11)
Gene therapy (343)
GLP-1 (179)
Government (770)
Grass and pollen (2)
Guidances (93)
Healthcare (3424)
HIV (15)
Huntington's disease (26)
IgA nephropathy (19)
Immunology and inflammation (50)
Immuno-oncology (10)
Indications (28)
Infectious disease (617)
Inflammatory bowel disease (40)
Inflation Reduction Act (9)
Influenza (23)
Intellectual property (47)
Interviews (134)
IPO (2470)
IRA (13)
Job creations (517)
Job search strategy (505)
JPM (23)
Kidney cancer (4)
Labor market (49)
Layoffs (111)
Leadership (16)
Legal (801)
Liver cancer (24)
Longevity (2)
Lung cancer (145)
Lymphoma (129)
Machine learning (11)
Management (15)
Manufacturing (169)
MASH (13)
Medical device (960)
Medtech (962)
Mergers & acquisitions (2807)
Metabolic disorders (260)
Multiple sclerosis (28)
NASH (1)
Neurodegenerative disease (85)
Neuropsychiatric disorders (14)
Neuroscience (716)
NextGen: Class of 2026 (1179)
Non-profit (993)
Now hiring (30)
Obesity (139)
Opinion (104)
Ovarian cancer (20)
Pain (27)
Pancreatic cancer (50)
Parkinson's disease (76)
Partnered (22)
Patents (79)
Patient recruitment (94)
Peanut (10)
People (9607)
Pharmaceutical (9)
Pharmacy benefit managers (3)
Phase 1 (4915)
Phase 2 (6208)
Phase 3 (4710)
Pipeline (1203)
Policy (74)
Postmarket research (331)
Preclinical (2181)
Press Release (18)
Prostate cancer (67)
Psychedelics (8)
Radiopharmaceuticals (40)
Rare diseases (470)
Real estate (749)
Recruiting (19)
Regulatory (4413)
Reports (27)
Research institute (887)
Resumes & cover letters (89)
Rett syndrome (26)
RNA editing (13)
RSV (15)
Schizophrenia (30)
Series A (52)
Series B (38)
Service/supplier (2)
Sickle cell disease (47)
Special edition (22)
Spinal muscular atrophy (139)
Sponsored (10)
Startups (791)
Stomach cancer (1)
Supply chain (19)
Tariffs (17)
The Weekly (12)
Vaccines (182)
Venture capital (22)
Weight loss (77)
Women's health (14)
Worklife (8)
Date
Last 7 days (121)
Last 30 days (470)
Last 365 days (6637)
2026 (616)
2025 (6759)
2024 (7712)
2023 (7966)
2022 (11766)
2021 (12096)
2020 (10060)
2019 (8483)
2018 (6189)
2017 (6120)
2016 (5629)
2015 (6331)
2014 (4423)
2013 (3560)
2012 (3444)
2011 (3376)
2010 (2904)
Location
Africa (252)
Alabama (5)
Alaska (2)
Arizona (28)
Arkansas (3)
Asia (6717)
Australia (1336)
California (2382)
Canada (497)
China (239)
Colorado (75)
Connecticut (120)
Delaware (69)
Europe (19460)
Florida (278)
Georgia (37)
Hawaii (1)
Idaho (9)
Illinois (180)
India (7)
Indiana (193)
Iowa (4)
Japan (121)
Kansas (10)
Kentucky (7)
Louisiana (6)
Maine (3)
Maryland (280)
Massachusetts (2113)
Michigan (89)
Minnesota (46)
Mississippi (1)
Missouri (7)
Montana (5)
Nebraska (5)
Nevada (18)
New Hampshire (3)
New Jersey (528)
New Mexico (5)
New York (630)
North Carolina (301)
North Dakota (6)
Northern California (1200)
Ohio (69)
Oklahoma (1)
Oregon (7)
Pennsylvania (521)
Puerto Rico (3)
Rhode Island (12)
South America (293)
South Carolina (3)
Southern California (906)
Tennessee (15)
Texas (282)
United States (8449)
Utah (144)
Virginia (66)
Washington D.C. (20)
Washington State (210)
West Virginia (2)
Wisconsin (18)
120,960 Results for "ares genetics gmbh".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Croma-Pharma GmbH Enters Strategic Distribution Partnership with Renellence in Canada
October 10, 2025
·
2 min read
Press Releases
IBA integrates Artificial Intelligence Quality Assurance into dosimetry solutions through the acquisition of PhantomX GmbH
November 3, 2025
·
2 min read
Press Releases
ARS Pharmaceuticals to Participate in Piper Sandler 37th Annual Healthcare Conference
November 27, 2025
·
1 min read
Business
OpGen Subsidiary Ares Genetics GmbH Enters into Collaboration Agreement with the Belgian National Reference Centre for Invasive S. pneumoniae at UZ Leuven
OpGen, Inc. announced today that its subsidiary Ares Genetics GmbH (Ares Genetics) and the Belgian National Reference Centre have entered into a collaboration agreement to jointly evaluate computational tools developed by Ares Genetics for the identification and characterization of Streptococcus pneumoniae for diagnostic purposes.
July 26, 2022
·
6 min read
Press Releases
Merck Signs Agreement with Dr. Falk Pharma GmbH for Certain Development and Commercialization Rights to MK-8690 (PRA-052) an Investigational Anti-CD30 Ligand Monoclonal Antibody
November 5, 2025
·
3 min read
Press Releases
Moderna Secures $1.5 Billion Five-Year Credit Facility from Ares Management
November 21, 2025
·
4 min read
Approvals
ARS Wins FDA Approval for Neffy Spray for Children in Anaphylaxis
Neffy 1 mg is the “first significant innovation” for epinephrine delivery in small children aged 4 years and up in over 35 years, according to ARS Pharmaceuticals.
March 6, 2025
·
2 min read
·
Tristan Manalac
Press Releases
ARS Pharmaceuticals Announces Conference Call and Webcast for its Third Quarter 2025 Financial Results
November 4, 2025
·
1 min read
Press Releases
Targeted Genomics Launches Celiac Genetic Testing Services for Texas Physicians
February 2, 2026
·
2 min read
Press Releases
ARS Pharmaceuticals Reports Third Quarter 2025 Financial Results and Highlights for neffy® (epinephrine nasal spray)
November 10, 2025
·
17 min read
1 of 12,096
Next
